Efficacy of Melodic Intonation Therapy in Patients with Chronic Broca’s Aphasia: Speech Language Pathology Perspective
Melodic Intonation Therapy in Chronic Broca’s Aphasia
DOI:
https://doi.org/10.54393/pbmj.v5i4.410Keywords:
Melodic Intonation Therapy in Chronic Broca’s AphasiaAbstract
Aphasia is a linguistic problem that occurs after brain damage. It's a broad term that encompasses everything from modest word retrieval challenges to a complete inability to produce and interpret language. Fluent and non-fluent aphasia are two types of aphasia. Non-fluent aphasia is characterized by sluggish, effortful speaking and is caused by a stroke in the left frontotemporal areas. These patients' language production is mainly limited to one- or two-word utterances. Non-fluent aphasic patients can sing fluently despite their significant language production handicap, which has led to the use of singing and music in aphasia rehabilitation. Objective: To examine the effectiveness of Melodic Intonation Therapy (MIT) in patients with chronic Broca's aphasia. Methods: A descriptive study was conducted from March 1 to September 30, 2021, at NUR International University to investigate the efficacy of MIT in patients with persistent Broca's aphasia. For this purpose data was collected from almost 50 speech therapists working with chronic Broca's aphasic patients through a self-designed questionnaire. The questionnaire was used as a data collecting instrument that was designed by expert opinion and literature review. Results: Results indicated that MIT is effective in patients with chronic Broca's aphasia. On asking the respondent about the efficacy of MIT almost 88% responded that MIT is effective, 8% were not sure about the efficacy of MIT and 4% responded MIT is not effective in chronic aphasic patients. On asking the respondent about the development of expressive language 64 % responded that expressive Language is improved while 36 % were not sure about the development of expressive language development. On asking the respondent whether MIT reduces psychological stress on individuals regarding the necessity to speak correctly, 88 % responded with yes while 12 % responded with No that MIT reduces psychological stress. Conclusions: It is concluded from this study that MIT is effective in patients with chronic Broca’s aphasia.
References
Mayeux R. Disorders of Language: The Aphasias. Principles of Neural science. 1991:839-51.
Lopez-Romero LA, Riano-Carreno DM, Pachon-Poveda MY, Mendoza-Sanchez JA and Leon-Vargas YK et al. Efficacy and safety of transcranial magnetic stimulation in patients with non-fluent aphasia, following an ischaemic stroke. A controlled, randomised and double-blind clinical trial. Rev Neurol. 2019;68(6):241-249. Spanish. doi: 10.33588/rn.6806.2018300.
Fridriksson J, Fillmore P, Guo D and Rorden C. Chronic Broca's Aphasia Is Caused by Damage to Broca's and Wernicke's Areas. Cereb Cortex. 2015;25(12):4689-96. doi: 10.1093/cercor/bhu152.
Spreen, O and Risser AH. Assessment of Aphasia. Oxford University Press, New York. 2003:45-49.
Jordan L and Kaiser W. Aphasia—A social approach. Springer. 2013.
Haro-Martínez A, Pérez-Araujo CM, Sanchez-Caro JM, Fuentes B and Díez-Tejedor E. Melodic Intonation Therapy for Post-stroke Non-fluent Aphasia: Systematic Review and Meta-Analysis. Front Neurol. 2021;12:700115. doi: 10.3389/fneur.2021.700115.
Norton A, Zipse L, Marchina S and Schlaug G. Melodic intonation therapy: shared insights on how it is done and why it might help. Ann N Y Acad Sci. 2009;1169:431-6. doi: 10.1111/j.1749-6632.2009.04859.x.
Greener J, Enderby P and Whurr R. Speech and language therapy for aphasia following stroke. Cochrane Database of Systematic Reviews. 1999(4). doi.org/10.1002/14651858.CD000425.
Mumby K and Whitworth A. Evaluating the effectiveness of intervention in long-term aphasia post-stroke: the experience from CHANT (Communication Hub for Aphasia in North Tyneside). Int J Lang Commun Disord. 2012;47(4):398-412. doi: 10.1111/j.1460-6984.2012.00153.x.
Basso A, Capitani E and Vignolo LA. Influence of rehabilitation on language skills in aphasic patients. A controlled study. Arch Neurol. 1979;36(4):190-6. doi: 10.1001/archneur.1979.00500400044005.
Robey RR. A meta-analysis of clinical outcomes in the treatment of aphasia. J Speech Lang Hear Res. 1998;41(1):172-87. doi: 10.1044/jslhr.4101.172.
Da Fontoura DR, Rodrigues JC, Carneiro LBS, Monção AM and de Salles JF. Rehabilitation of language in expressive aphasias: a literature review. Dement Neuropsychol. 2012;6(4):223-235. doi: 10.1590/S1980-57642012DN06040006.
Von Kerckerinck TL. Know thyself: A first-person hermeneutic phenomenological study of the lived experience of using the shamanic sacred plant medicines ayahuasca and Willka (Doctoral dissertation, Saybrook University). 2014.
Jang SH. Diffusion tensor imaging studies on arcuate fasciculus in stroke patients: a review. Front Hum Neurosci. 2013;7:749. doi: 10.3389/fnhum.2013.00749.
Greener J, Enderby P and Whurr R. Speech and language therapy for aphasia following stroke. Cochrane Database Syst Rev. 2000;(2):CD000425. doi: 10.1002/14651858.CD000425.
van der Meulen I, van de Sandt-Koenderman WM, Heijenbrok-Kal MH, Visch-Brink EG and Ribbers GM. The Efficacy and Timing of Melodic Intonation Therapy in Subacute Aphasia. Neurorehabil Neural Repair. 2014;28(6):536-44. doi: 10.1177/1545968313517753.
Doogan C, Dignam J, Copland D and Leff A. Aphasia Recovery: When, How and Who to Treat? Curr Neurol Neurosci Rep. 2018;18(12):90. doi: 10.1007/s11910-018-0891-x.
Yu ZZ, Jiang SJ, Jia ZS, Xiao HY and Zhou MQ. Study on Language Rehabilitation for Aphasia. Chin Med J (Engl). 2017;130(12):1491-1497. doi: 10.4103/0366-6999.207465.
Marshall CR, Hardy CJD, Volkmer A, Russell LL, Bond RL and Fletcher PD et al. Primary progressive aphasia: a clinical approach. J Neurol. 2018;265(6):1474-1490. doi: 10.1007/s00415-018-8762-6.
Berube S and Hillis AE. Advances and Innovations in Aphasia Treatment Trials. Stroke. 2019;50(10):2977-2984. doi: 10.1161/STROKEAHA.119.025290.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Pakistan BioMedical Journal
This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an open-access journal and all the published articles / items are distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. For comments editor@pakistanbmj.com